Skip to main content
RENT.COM.AU LIMITED logo

RENT.COM.AU LIMITED — Investor Relations & Filings

Ticker · RNT ISIN · AU000000RNT0 ASX Real estate activities
Open in API
Filings indexed 1,229 across all filing types
Latest filing 2005-12-14 Regulatory Filings
Country AU Australia
Listing ASX RNT

About RENT.COM.AU LIMITED

https://www.rent.com.au

Rent.com.au Limited operates a digital platform focused on the rental property market, connecting tenants with property managers and private landlords. The company provides a suite of technology-driven products designed to simplify the rental lifecycle. Key services include a property listing portal, RentCheck for tenant verification and identity reports, and RentBond, which offers financing solutions for rental bonds. The company also offers RentConnect for utility connection services and RentPay, a specialized payment application that enables tenants to manage and automate their rent payments while offering landlords streamlined reconciliation. These tools are integrated to provide a seamless experience for users navigating the rental process, from initial search and application to ongoing tenancy management and financial transactions.

Recent filings

Filing Released Lang Actions
Trading Halt 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is a market release announcing a trading halt for Select Vaccines Limited securities pending a forthcoming announcement. It is a short notice about trading status, not a financial report or detailed filing. There is no financial data, no report attached or referenced beyond the trading halt itself. This fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2005-12-14 English
Hepatitis C Vaccine Program 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 9 December 2005 from Select Vaccines Limited. It clarifies a previous announcement about the Hepatitis C Vaccine Program, specifically about the prospects of developing a human vaccine for clinical trials. The document is short (1011 characters) and serves as a clarification or update rather than a detailed report or financial statement. It does not contain financial data, management changes, voting results, or other report types. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories.
2005-12-08 English
Supplementary Disclosure Document 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is titled 'ASX ANNOUNCEMENT' and is a 'Supplementary Prospectus' dated 9 December 2005. It supplements a previous prospectus dated 22 November 2005. The text includes a notice that the supplementary prospectus was lodged with the Australian Securities and Investments Commission and the Australian Stock Exchange. It also contains a directors' consent section. The document is relatively short (2823 characters) and primarily serves as an announcement of the supplementary prospectus rather than the full prospectus itself. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement and not a full financial report or prospectus document. Therefore, the appropriate classification is Regulatory Filings (RNS).
2005-12-08 English
Disclosure Document 26 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for a non-renounceable pro-rata rights issue by Select Vaccines Limited. It includes information about the offer, timetable, underwriting, company overview, and use of funds. The document is not a financial report, earnings release, or management discussion, but rather a capital raising document aimed at shareholders to participate in a rights issue. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length and content confirm it is the actual prospectus, not just an announcement or summary.
2005-11-22 English
Proposed Pro-Rata Share Issue 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement from Select Vaccines Limited regarding a proposed pro-rata share issue. It details the terms of the share offer, including the issue price, underwriting, purpose of the capital raise, and the timetable for the offer. There is no financial report, earnings data, or detailed financial statements included. The document is focused on informing shareholders and the market about a capital raising event through a share issue. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is under 5,000 characters and is not a report publication announcement or certification. Therefore, the correct classification is CAP with high confidence.
2005-11-21 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and contains detailed information about a new issue announcement, application for quotation of additional securities, and agreement. It includes specifics such as the class of securities issued, number of securities, issue price, purpose of the issue, dates related to securities, underwriting details, and quotation application. The content is consistent with a capital raising or financing activity, specifically a new share issue and rights issue. There is no indication of financial statements, audit information, management discussion, or earnings data. The document is not a report but an announcement related to capital structure changes. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length and detail support a high confidence in this classification.
2005-11-21 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.